NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Nuvation Bio Inc. Share Price Chart

O H L

Nuvation Bio Inc. Performance Overview

Days Range
$6.04Low
$6.15High

Markets Today

Previous Close$6.07
Open$6.08
Volume895,016
Day's Range$6.04 - $6.15
52W Range$2.99 - $9.75
Market Cap$2.03 B

Historical Performance

1M Returns-12.79
3M Returns+9.17
6M Returns+41.82
1Y Returns+91.48
5Y Returns-37.10
10Y ReturnsNA

Nuvation Bio Inc. Fundamentals

Market Cap$2.03 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$62.90 M
ROE TTM-0.53
EPS TTM$-0.44
Quarterly Earnings Growth YOYN/A
PB Ratio7.96
EBITDA$-211.32 M
Profit Margin-325.31
Market Cap$2.03 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$62.90 M
ROE TTM-0.53
EPS TTM$-0.44
Quarterly Earnings Growth YOYN/A
PB Ratio7.96
EBITDA$-211.32 M
Profit Margin-325.31

Nuvation Bio Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$3.08 M$4.83 M$13.12 M$41.87 M$83.23 M$31.69 M
Gross Profit +$990.00 K$2.43 M$9.77 M$41.44 M$77.61 M$23.13 M
Operating Income -$59.00 M-$63.59 M-$56.60 M-$33.48 M$3.88 M-$51.04 M
EBITDA -$58.69 M-$63.23 M-$56.07 M-$32.94 M$4.42 M-$50.50 M
Interest Expense -$54.00 K-$421.00 K-$6.53 M-$6.67 M-$6.71 M-$6.76 M
Depreciation $310.00 K$356.00 K$534.00 K$539.00 K$536.00 K$536.00 K
Income Before Tax -$53.24 M-$59.01 M-$55.79 M-$36.59 M$5.40 M-$62.84 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$53.24 M-$59.01 M-$55.79 M-$36.59 M$5.40 M-$62.84 M
Net Profit Margin -1726.2%-1220.92%-425.24%-87.4%6.48%-198.31%

Nuvation Bio Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.38 B$1.40 B$1.40 B$1.42 B$1.43 B$1.43 B
Reserve & Surplus -$963.43 M-$1.02 B-$1.08 B-$1.12 B-$1.11 B-$1.18 B
Non-Current Liabilities $20.26 M$207.96 M$207.55 M$206.88 M$211.16 M$403.88 M
Current Liabilities $52.77 M$66.36 M$68.13 M$82.23 M$79.52 M$86.75 M
Total Liabilities $73.03 M$274.32 M$275.68 M$289.11 M$290.68 M$490.64 M
Fixed Assets $4.97 M$12.76 M$12.24 M$11.78 M$11.29 M$11.01 M
Current Assets $475.57 M$623.21 M$577.53 M$571.52 M$591.53 M$726.43 M
Total Assets $492.49 M$647.23 M$601.56 M$594.82 M$610.24 M$744.50 M

Nuvation Bio Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$53.24 M-$59.01 M-$55.79 M-$36.59 M$5.40 M-$62.84 M
Operating Cash Flow -$42.63 M-$48.18 M-$52.89 M-$29.73 M$5.07 M-$42.97 M
Investing Cash Flow $54.18 M$54.88 M-$96.62 M$87.08 M-$43.64 M$5.99 M
Financing Cash Flow $548.00 K$193.42 M$501.00 K$8.06 M$44.00 K$170.53 M
Change in Cash $12.25 M$199.99 M-$149.07 M$65.19 M-$38.70 M$133.21 M

Nuvation Bio Inc. Return Calculator

The Nuvation Bio Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$6,249
Invested Amount$10,000
Est. Returns$-3,751
Invest in USA Stock Today

About Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

FAQs

Nuvation Bio Inc. (NUVB) share price as of September 18, 2026 is $6.03. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Nuvation Bio Inc. (NUVB) Share by opening an international trading account with Angel One.
Purchasing Nuvation Bio Inc. (NUVB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Nuvation Bio Inc. (NUVB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Nuvation Bio Inc. (NUVB) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Nuvation Bio Inc. on September 18, 2026, is $2.03 B.
Nuvation Bio Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Nuvation Bio Inc. (NUVB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91